MH
Michael B Hoffman
Director

Michael B Hoffman insider trades: Annovis Bio (ANVS) stock buys and sales

Director, Annovis Bio Last trade Nov 6, 2026 41 Form 4 filings
$0
Sold, last 12 months
0 sales
$7.1M
Bought, last 12 months
7 buys
20
Open-market trades
since 2005
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

20 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 6, 2026ANVS↑ Buy$5.0M
May 20, 2026ANVS↑ Buy$143K
Apr 2, 2026ANVS↑ Buy$1.5M
Dec 8, 2025ANVS↑ Buy$194K
Nov 24, 2025ANVS↑ Buy$160K
Nov 21, 2025ANVS↑ Buy$70K
Nov 14, 2025ANVS↑ Buy$32K
Oct 28, 2025ANVS↑ Buy$2.0M
Aug 27, 2020ONTX↓ Sell$50K
Aug 27, 2020ONTX↓ Sell$510
Jan 31, 2020ANVS↑ Buy$200K
Aug 29, 2018ONTX↓ Sell$45K
Feb 21, 2014ONTX↑ Buy10b5-1$1.2M
Jan 27, 2014ONTX↑ Buy10b5-1$683K
Nov 22, 2013ONTX↑ Buy$72K
Nov 18, 2013ONTX↑ Buy$59K
Nov 15, 2013ONTX↑ Buy$236K
Jul 30, 2013ONTX↑ Buy$15.0M
Sep 20, 2006BPL↓ Sell$485K
Jun 8, 2005BPL↑ Buy$372K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael B Hoffman's insider trades

Michael B Hoffman is a director at Annovis Bio (ANVS). Since Jun 8, 2005, Michael has reported 16 open-market purchases worth $26.9M and 4 sales worth $580K on SEC Form 4. In the last 12 months: 7 buys ($7.1M).

Their filings also include grants and awards (18 filings), other transactions (3 filings), option exercises (3 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.